Cortland Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $477K | Buy |
3,711
+15
| +0.4% | +$1.76K | 0.07% | 44 |
|
|
2026
Q1 | $445K | Sell |
3,696
-884
| -19% | -$102K | 0.06% | 42 |
|
|
2025
Q4 | $482K | Sell |
4,580
-1,123
| -20% | -$105K | 0.06% | 40 |
|
|
2025
Q3 | $479K | Buy |
5,703
+40
| +0.7% | +$3.29K | 0.06% | 43 |
|
|
2025
Q2 | $448K | Buy |
5,663
+40
| +0.7% | +$3.18K | 0.05% | 41 |
|
|
2025
Q1 | $505K | Buy |
5,623
+32
| +0.6% | +$2.99K | 0.06% | 39 |
|
|
2024
Q4 | $556K | Buy |
5,591
+28
| +0.5% | +$2.89K | 0.06% | 38 |
|
|
2024
Q3 | $632K | Buy |
5,563
+24
| +0.4% | +$2.85K | 0.08% | 36 |
|
|
2024
Q2 | $686K | Buy |
5,539
+23
| +0.4% | +$2.96K | 0.09% | 35 |
|
|
2024
Q1 | $728K | Sell |
5,516
-129
| -2% | -$15.9K | 0.09% | 35 |
|
|
2023
Q4 | $615K | Buy |
5,645
+27
| +0.5% | +$2.8K | 0.09% | 36 |
|
|
2023
Q3 | $578K | Sell |
5,618
-65
| -1% | -$7.01K | 0.09% | 35 |
|
|
2023
Q2 | $656K | Sell |
5,683
-1,032
| -15% | -$117K | 0.11% | 35 |
|
|
2023
Q1 | $714K | Buy |
6,715
+155
| +2% | +$16.7K | 0.11% | 33 |
|
|
2022
Q4 | $728K | Sell |
6,560
-170
| -3% | -$17.4K | 0.12% | 32 |
|
|
2022
Q3 | $580K | Buy |
6,730
+101
| +2% | +$9.02K | 0.1% | 36 |
|
|
2022
Q2 | $604K | Buy |
6,629
+675
| +11% | +$59.8K | 0.1% | 38 |
|
|
2022
Q1 | $489K | Sell |
5,954
-75
| -1% | -$5.91K | 0.06% | 38 |
|
|
2021
Q4 | $462K | Buy |
6,029
+75
| +1% | +$5.97K | 0.05% | 44 |
|
|
2021
Q3 | $447K | Hold |
5,954
| – | – | 0.05% | 44 |
|
|
2021
Q2 | $463K | Sell |
5,954
-286
| -5% | -$21.3K | 0.05% | 42 |
|
|
2021
Q1 | $459K | Hold |
6,240
| – | – | 0.05% | 40 |
|
|
2020
Q4 | $487K | Hold |
6,240
| – | – | 0.06% | 40 |
|
|
2020
Q3 | $494K | Sell |
6,240
-101
| -2% | -$7.91K | 0.07% | 39 |
|
|
2020
Q2 | $468K | Sell |
6,341
-58
| -0.9% | -$4.37K | 0.07% | 37 |
|
|
2020
Q1 | $470K | Sell |
6,399
-56
| -0.9% | -$4.4K | 0.09% | 30 |
|
|
2019
Q4 | $560K | Buy |
6,455
+215
| +3% | +$17.7K | 0.08% | 34 |
|
|
2019
Q3 | $501K | Sell |
6,240
-29
| -0.5% | -$2.32K | 0.09% | 31 |
|
|
2019
Q2 | $502K | Hold |
6,269
| – | – | 0.08% | 34 |
|
|
2019
Q1 | $498K | Sell |
6,269
-3,972
| -39% | -$297K | 0.08% | 34 |
|
|
2018
Q4 | $747K | Sell |
10,241
-68
| -0.7% | -$4.8K | 0.14% | 26 |
|
|
2018
Q3 | $698K | Sell |
10,309
-20
| -0.2% | -$1.27K | 0.11% | 28 |
|
|
2018
Q2 | $598K | Hold |
10,329
| – | – | 0.1% | 29 |
|
|
2018
Q1 | $537K | Hold |
10,329
| – | – | 0.09% | 30 |
|
|
2017
Q4 | $555K | Buy |
10,329
+731
| +8% | +$40.5K | 0.1% | 29 |
|
|
2017
Q3 | $586K | Sell |
9,598
-711
| -7% | -$43.1K | 0.11% | 24 |
|
|
2017
Q2 | $630K | Hold |
10,309
| – | – | 0.12% | 23 |
|
|
2017
Q1 | $625K | Hold |
10,309
| – | – | 0.13% | 31 |
|
|
2016
Q4 | $579K | Sell |
10,309
-67
| -0.6% | -$3.92K | 0.12% | 31 |
|
|
2016
Q3 | $618K | Buy |
+10,376
| New | +$607K | 0.13% | 32 |
|
Other funds holding MRK
ECSS
Cortland Associates's MRK Position: Q2 2026 in Review
Cortland Associates increased its Merck (MRK) stake by 0.41% in Q2 2026, buying an estimated $1.76K and bringing the position to 3,711 shares worth $477K. The position accounts for 0.07% of the portfolio, ranked #44.
Cortland Associates first reported a position in MRK in Q3 2016 and has held it in 40 quarters since. The position peaked at $747K in Q4 2018. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cortland Associates held 3,711 shares of Merck worth $477K as of Q2 2026.
- Cortland Associates bought 15 Merck shares in Q2 2026, an estimated $1.76K.
- Merck made up 0.07% of Cortland Associates's portfolio in Q2 2026, its #44 holding.
- Cortland Associates first reported a position in Merck in Q3 2016 and has held it in 40 quarters since.
- Cortland Associates's Merck position peaked at $747K in Q4 2018.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cortland Associates's 13F filing for Q2 2026, filed 28 Jul 2026.